Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ventzislav Vassilev"'
Autor:
Nicolas Lecrenier, Pierre Beukelaers, Romulo Colindres, Desmond Curran, Carine De Kesel, Jean-Philippe De Saegher, Arnaud M Didierlaurent, Edouard Y Ledent, Johann F Mols, Tomas Mrkvan, Marie Normand-Bayle, Lidia Oostvogels, Fernanda Tavares Da Silva, Ventzislav Vassilev, Carlota Vinals, Alain Brecx
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 7, Pp 619-634 (2018)
Introduction: GSK has developed a two-dose adjuvanted recombinant zoster vaccine (Shingrix, RZV) to protect people aged ≥50 years (50+) against herpes zoster (HZ) and its complications. RZV showed >90% efficacy against HZ, sustained over 4 years of
Externí odkaz:
https://doaj.org/article/1b760f751a8344c4b6a80c0fa43d527a
Autor:
Felicity Hartnell, Anthony Brown, Stefania Capone, Jakub Kopycinski, Carly Bliss, Shokouh Makvandi-Nejad, Leo Swadling, Emma Ghaffari, Paola Cicconi, Mariarosaria Del Sorbo, Roberta Sbrocchi, Ilaria Esposito, Ventzislav Vassilev, Paula Marriott, Clair M. Gardiner, Ciaran Bannan, Colm Bergin, Matthias Hoffmann, Bethany Turner, Alfredo Nicosia, Antonella Folgori, Tomáš Hanke, Eleanor Barnes, Lucy Dorrell
Publikováno v:
Frontiers in Immunology, Vol 9 (2019)
Background: Nearly 3 million people worldwide are coinfected with HIV and HCV. Affordable strategies for prevention are needed. We developed a novel vaccination regimen involving replication-defective and serologically distinct chimpanzee adenovirus
Externí odkaz:
https://doaj.org/article/618c2f9ea245477997abb43b537f46c5
Autor:
Kimberly E Rousseau, Elisa Scarselli, Matthew E. Winter, Kimberly Page, Karla Thornton, Ellen Stein, Andrea L. Cox, Michael R. Wierzbicki, Paula J. Lum, Soju Chang, Antonella Folgori, Alfredo Nicosia, Guido Massaccesi, Michael Forman, Katherine Wagner, Marc G. Ghany, Alice Asher, Linda C. Giudice, T. Jake Liang, Elaine Thomas, Stefania Capone, William O. Osburn, Rebecca T. Veenhuis, Lan Lin, Richard L. Gorman, Michael T. Melia, Ventzislav Vassilev
Publikováno v:
N Engl J Med
The New England journal of medicine, vol 384, iss 6
The New England journal of medicine, vol 384, iss 6
BACKGROUND: A safe and effective vaccine to prevent chronic hepatitis C virus (HCV) infection is a critical component of efforts to eliminate the disease. METHODS: In this phase 1–2 randomized, double-blind, placebo-controlled trial, we evaluated a
Autor:
Antonella Folgori, Stefano Colloca, Paul Klenerman, Cinzia Traboni, Eleanor Barnes, Stefania Capone, Alfredo Nicosia, Anthony Brown, Felicity Hartnell, Leo Swadling, Ventzislav Vassilev, Riccardo Cortese, Mariarosaria Del Sorbo
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 5, Iss 1, Pp 1-14 (2020)
npj Vaccines, Vol 5, Iss 1, Pp 1-14 (2020)
Simian adenoviral and modified vaccinia Ankara (MVA) viral vectors used in heterologous prime-boost strategies are potent inducers of T cells against encoded antigens and are in advanced testing as vaccine carriers for a wide range of infectious agen
Autor:
T. Jake Liang, Antonella Folgori, Alice Asher, Rebecca T. Veenhuis, Katherine Wagner, Soju Chang, Kimberly Page, Linda C. Giudice, Stefania Capone, Marc G. Ghany, Peter Wolff, Michael R. Wierzbicki, Elisa Scarselli, Alfredo Nicosia, Lan Lin, Guido Massaccesi, Ellen Stein, Richard L. Gorman, Paula J. Lum, William O. Osburn, Ventzislav Vassilev, Andrea L. Cox, Michael T. Melia
Publikováno v:
Open Forum Infectious Diseases
Background The development of a safe and effective vaccine to prevent chronic hepatitis C virus (HCV) infection is a critical component of elimination efforts, providing the rationale for the first HCV vaccine efficacy trial. Methods In a randomized,
Autor:
Pierre Vandepapelière, Frédéric Clement, Isabel Leroux-Roels, Edouard Ledent, Ventzislav Vassilev, Thomas C. Heineman, Geert Leroux-Roels
Publikováno v:
The Journal of Infectious Diseases. 206:1280-1290
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being developed for the prevention of herpes zoster and its complications. Methods. In a phase I/II, open-label, randomized, parallel-group study, older adults (50-
Autor:
Richard G. Jarman, Chonticha Klungthong, Nadine Sadon, Ventzislav Vassilev, Anne Delers, Robert V. Gibbons, Ananda Nisalak
Publikováno v:
Journal of Virological Methods. 153:1-6
In order to detect and identify dengue serotypes in serum samples, we developed a single-step quantitative reverse transcription-polymerase chain reaction (Q-RT-PCR) assay (referred to as Q-PCR). Sets of primers were selected from the capsid region o
Autor:
Ventzislav Vassilev
Publikováno v:
Journal of Clinical Microbiology. 43:5415-5417
Recently, Dr. Sauerbrei and his colleagues reported ([8][1]) on the genetic profile of an Oka varicella vaccine virus variant (V-Oka-zoster) isolated from an infant with herpes zoster. Those authors hypothesized that the isolated variant had an incre
Autor:
Elizabeth Thomas, Ganesh M. Sathe, Sueli L. Tillieux, John J. Voycik, Ventzislav Vassilev, Wendy S. Halsey
Publikováno v:
Journal of virology. 82(22)
Varicella-zoster virus (VZV) is a herpesvirus and is the causative agent of chicken pox (varicella) and shingles (herpes zoster). Active immunization against varicella became possible with the development of live attenuated varicella vaccine. The Oka
Autor:
Anjeanette Roberts, Elaine W. Lamirande, Leatrice Vogel, Benoît Baras, Geneviève Goossens, Isabelle Knott, Jun Chen, Jerrold M. Ward, Ventzislav Vassilev, Kanta Subbarao
Publikováno v:
Viral Immunology; Oct2010, Vol. 23 Issue 5, p509-519, 11p